Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 24 ... outcomes with other minimally invasive techniques are needed to define clinical efficacy as it pertains to subsets of patients with variable stone size, location, and ... concluded: "This technique is in its early stage of implementation and randomized trials that compare robot-assisted outcomes with other minimally invasive techniques are needed ...
2009 NOV 29 ... Genetics, Ghent University Hospital in Belgium, and colleagues evaluated the antitumor efficacy of nutlin-3, a potent and selective antagonist of the p53-MDM2 ... growth and metastasis."These findings support the initiation of clinical trials of selective MDM2 antagonists for treatment of advanced-stage and chemoresistant ...
2009 NOV 29 ... in Family Medicine Practices Safe and Effective In a study validating the safety and efficacy of early abortion care by family physicians, researchers find the rates of complications ... and Important Undisclosed Changes Made to Outcomes of Published Randomized Controlled Trials Authors frequently change the outcomes of clinical trials between trial registration and ...
2009 NOV 28 ... approved for the treatment of ADHD. In clinical trials, INTUNIV provided significant efficacy across the spectrum of ADHD symptoms that can be disruptive, such as being easily ...
2009 NOV 28 ... is needed to further verify the viral vectors used by the researchers, to evaluate the efficacy of this approach in larger animal models and to explain the molecular reasons for its ... Pediatrics, Biochemical, Cancer Gene Therapy, Central Nervous System Injury, Clinical Trials, Hematology, Hematopoietic, Heparin, Lysosomal Storage Disease, Mucopolysaccharidoses, ...
Subject: Cincinnati Children's Hospital Medical Center
2009 NOV 23 ... based on Sol-Gel's patented drug delivery system that is designed to enhance the efficacy, safety and stability of topical drugs. Sol-Gel's technology does so by encapsulating ... Keywords: , Women, Technology, Software, Nanotechnology, Health, Clinical Trials, Genetics, Pharmaceutical, Other Heal, Food, Science & Technology, Technology, ...
2009 NOV 23 ... painful, or unsafe when administered long term. Biologic therapies have demonstrated efficacy for plaque psoriasis and psoriatic arthritis; these therapies may be particularly ... Index, a helpful tool that, upon validation, will allow comparison across treatments and trials," wrote A.K. Gupta and colleagues. The researchers concluded: ...
2009 NOV 26 ... urinary tract infection, but adequately powered, placebo-controlled trials regarding efficacy are lacking. This study from four Australian centers examined whether low-dose, ...
2009 NOV 23 ... (FGAs), with most finding better efficacy and tolerability for SGAs. However, these 'efficacy trials' were generally short term and included only highly selected patients." ...
2009 NOV 23 ... cervical, vaginal, and vulvar disease through 3 years. We provide an update on the efficacy of the quadrivalent HPV vaccine against high-grade cervical, vaginal, and vulvar lesions ... cervical, vaginal, and vulvar lesions based on end-of-study data from three clinical trials," investigators in Copenhagen, Denmark report. "Additionally, we stratify ...
2009 NOV 23 ... nanomedicine for clinical trials, in this communication we have tested the preclinical efficacy of squalenoyl gemcitabine nanomedicine on several human tumor cell lines and on the ...
2009 NOV 23 ... have been shown to greatly reduce the risk of stroke. However, despite their proven efficacy, VKAs remain underused, particularly among elderly patients with AF. The preponderance ... among elderly patients with AF. The preponderance of evidence from randomized trials and observational studies attests to higher bleeding rates among elderly individuals ...
2009 NOV 23 ... clinical trials with measured clinical endpoints in MS patients to establish safety, efficacy and immunogenicity in this patient population. Keywords: , Health, ...
2009 NOV 23 ... therapy. We are looking forward to building upon our promising preclinical safety and efficacy data to establish clinical safety and proof of concept in this tumor type." ... cancer, with one currently available to patients and another in Phase 3 clinical trials. There is also a CYP17 lyase inhibitor currently in Phase 3 clinical trials and the ...
2009 NOV 23 ... produced similar results in non-human primates, in a translational study to demonstrate efficacy in safety in a species more closely related to humans. Non-human primates that received ... appearing in Science Translational Medicine puts scientists one step closer to clinical trials to test a gene delivery strategy to improve muscle mass and function in patients with ...
2009 NOV 23 ... SFA William A. Gray, MD, presented interim 6-month clinical results on the safety and efficacy of the FlexStent femoropopliteal self-expanding stent system (Flexible Stenting ... on the treatment of peripheral arterial disease were presented in the late-breaking trials session of the VIVA 2009: Vascular Interventional Advances annual meeting held on ...
2009 NOV 29 ... Logstrup, director of the EHN, regrets that, as a result, "safety and efficacy of several drugs have been evaluated predominantly in male ... underrepresented in cardiovascular research in Europe. "In the 62 randomized clinical trials published between 2006 and July 2009, only 33.5% of enrolled participants were women," ...
2009 NOV 23 ... soft tissue sarcoma. As previously announced, having achieved the study-specified efficacy milestone following planned safety and efficacy review by the Data Committee, a panel of ... Board, whose experience includes having served as lead investigator in the clinical trials leading to the approval of GleevecTM and Sutent TM to treat GIST, a form of soft tissue ...
2009 NOV 23 ... II trial in metastatic or unresectable soft tissue sarcoma achieved the study-specified efficacy milestone following planned safety and efficacy review by the Data Committee, a panel of ... T-cell lymphoma, also as early as the first half of 2010. The oral darinaparsin Phase I trials continue enrollment in order to establish the best dose and schedule. Oral indibulin ...
